Prognostic value of the maximum standardized uptake value of staging FDG-PET/CT in Hodgkin lymphoma.

被引：0
|
作者：
Hu, Boyu
Potluri, Alekhya
Torigian, Drew A.
Heltjan, Daniel F.
Nasta, Sunita
Schuster, Stephen J.
Svoboda, Jakub
机构：
[1] Hosp Univ Penn, Internal Med, Philadelphia, PA 19104 USA
[2] Hosp Univ Penn, Radiol, Philadelphia, PA 19104 USA
[3] Hosp Univ Penn, Biostat & Epidemiol, Philadelphia, PA 19104 USA
[4] Univ Penn, Div Hematol Oncol, Philadelphia, PA 19104 USA
[5] Hosp Univ Penn, Div Hematol Oncol, Philadelphia, PA 19104 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e19552
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19552
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Prognostic value of staging FDG PET/CT in breast cancer
    Han, E.
    Oh, J.
    O, J.
    Park, Y.
    Kang, S.
    Chung, S.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S354 - S354
  • [32] The prognostic value of FDG-PET measured by Standardized Uptake Value in patients with melanoma stage III; evaluated in a prospective study
    Bastiaannet, E.
    Hoekstra, O. S.
    De Jong, J. R.
    Brouwers, A. H.
    Suurmeijer, A. J.
    Hoekstra, H. J.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2010, 17 : S113 - S114
  • [33] Prognostic implication of the maximum standardized uptake value (mSUV) on 18F FDG-PET in patients with metastatic hepatocellular carcinoma
    Shin, D.
    Han, S.
    Oh, D.
    Im, S.
    Kim, T.
    Bang, Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [34] The prognostic value of FDG-PET measured by standardized uptake value in patients with melanoma stage III evaluated in a prospective study
    Bastiaannet, E.
    De Jong, J. R.
    Brouwers, A. H.
    Suurmeijer, A. J.
    Hoekstra, H. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [35] Prognostic significance of the standardized uptake value on early 18FDG-PET in patients with lymphoma
    Ahmadzadehfar, H.
    Rodrigues, M.
    Zojer, N.
    Knoll, P.
    Ludwig, H.
    Mirzaei, S.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S263 - S263
  • [36] Is ceCT necessary beyond FDG-PET/CT for primary staging in Hodgkin lymphoma?
    Kornelia, Kajary
    Zsuzsa, Molnar
    Szabolcs, Szakall, Jr.
    Peter, Molnar
    Zsolt, Lengyel
    [J]. ORVOSI HETILAP, 2014, 155 (06) : 226 - 230
  • [37] FDG-PET in the Staging of Patients with Hodgkin's Lymphoma
    Castagnoli, A.
    Versari, A.
    Rigacci, L.
    Gallamini, A.
    Matteini, M.
    Gregianin, M.
    Bianchi, A.
    Peano, S.
    Merli, F.
    Vaggelli, L.
    Levis, A.
    Chisesi, T.
    Pelosi, E.
    Biggi, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S145 - S145
  • [38] THE VALUE OF FDG-PET/CT IN ASSESSMENT OF PATIENTS WITH NON-HODGKIN'S LYMPHOMA OF TONSIL
    Tamam, M. Oner
    [J]. LEUKEMIA RESEARCH, 2017, 61 : S20 - S20
  • [39] The value of FDG-PET/CT in assessment of patients with Non-Hodgkin's Lymphoma of the Tonsil
    Tamam, M. O.
    Mulazimoglu, M.
    Tumar, I.
    Birol, E.
    Ozpacaci, T.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S469 - S469
  • [40] Unproven value of end-of-treatment FDG-PET in Hodgkin lymphoma
    Adams, Hugo J. A.
    Kwee, Thomas C.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (11) : 1934 - 1936
12345